Related Experiment Video
Updated: Apr 18, 2026
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.7K
Management of epilepsy in resource-limited settings
Roberto Caraballo1, Natalio Fejerman1
1Neurology Department, Hospital de Pediatría JP Garrahan, Buenos Aires, Argentina.
Epileptic Disorders : International Epilepsy Journal with Videotape
|January 31, 2015
Summary
Epilepsy affects millions globally, with 80% of cases in low-income nations lacking treatment. Improving care requires national programs and referral networks for accessible, cost-effective epilepsy management.
Area of Science:
- Neurology
- Global Health
- Epidemiology
Background:
- Epilepsy is a common neurological disorder affecting over 65 million people worldwide.
- Prevalence is higher in low- and middle-income countries, where access to care is limited.
- Up to 90% of epilepsy patients in resource-limited settings receive no treatment.
Purpose of the Study:
- To provide an overview of the current situation of epilepsy care globally.
- To review the needs and ongoing efforts in managing epilepsy, particularly in resource-limited countries.
- To highlight the challenges and potential solutions for improving epilepsy care.
Main Methods:
- Review of existing literature and data on epilepsy prevalence and incidence.
- Analysis of the challenges in providing epilepsy care in resource-limited settings.
- Examination of current strategies and programs aimed at improving epilepsy management.
Main Results:
- Epilepsy affects a significant global population, with a disproportionate burden in low-income countries.
- Lack of treatment and resources are major barriers to effective epilepsy care in many regions.
- National epilepsy programs and referral networks are crucial for comprehensive care delivery.
Conclusions:
- Addressing the global epilepsy challenge requires targeted interventions in resource-limited settings.
- Strengthening healthcare infrastructure and ensuring access to affordable antiepileptic drugs (AEDs) are essential.
- Collaborative efforts between healthcare professionals and policymakers are needed to improve the lives of people with epilepsy.
More Related Videos
Related Concept Videos
01:24Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
01:08Antiepileptic Drugs: Sodium Channel Blockers
2.5K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.5K
01:22Epilepsy ll: Types
1
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
1
01:14Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.8K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.8K
01:20Seizures l: Introduction
2
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
2